RoodMicrotec N.V. financials
RoodMicrotec N.V.
724500KT5PE9BZOF6F18 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | €16.5M | €14.3M |
| Gross profit | €16.5M | €14.5M |
| Other income | €78.0K | €258.0K |
| Employee benefits expense | €7.5M | €6.8M |
| Raw materials & consumables used | €2.7M | €2.6M |
| Depreciation & amortisation | €1.4M | €1.6M |
| Operating profit (EBIT) | €2.5M | €1.2M |
| Finance costs | €188.0K | €189.0K |
| Profit before tax | €2.3M | €1.0M |
| Income tax expense | -€109.0K | -€397.0K |
| Profit for the year | €2.4M | €1.4M |
| — attributable to owners | €2.4M | €1.4M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | €2.7M | €1.6M |
| Per share | ||
| Basic EPS | €0.03 | €0.02 |
| Diluted EPS | €0.03 | €0.02 |
| Free cash flow / share | €0.02 | €0.02 |
| Cash flow statement | ||
| Cash generated from operations | €3.7M | €2.2M |
| Net cash from operating activities | €3.6M | €2.0M |
| Net cash from investing activities | -€1.7M | -€673.0K |
| Purchase of PP&E (capex) | €1.7M | €557.0K |
| Purchase of intangibles | €2.0K | €124.0K |
| Net cash from financing activities | -€686.0K | -€169.0K |
| Repayments of borrowings | €0 | €792.0K |
| Lease liability payments | €286.0K | €278.0K |
| Balance sheet | ||
| Total assets | €17.2M | €15.0M |
| Non-current assets | €10.9M | €10.3M |
| Property, plant & equipment | €6.4M | €5.7M |
| Right-of-use assets | €350.0K | €458.0K |
| Intangible assets & goodwill | €2.0M | €2.1M |
| Current assets | €6.3M | €4.7M |
| Inventories | €86.0K | €98.0K |
| Trade & other receivables | €2.1M | €1.7M |
| Cash & equivalents | €3.7M | €2.6M |
| Total equity | €7.8M | €5.6M |
| — attributable to owners | €5.9M | €3.1M |
| Non-controlling interests | €2.0M | €2.5M |
| Non-current liabilities | €6.6M | €7.3M |
| Lease liabilities (non-current) | €80.0K | €220.0K |
| Current liabilities | €2.7M | €2.1M |
| Lease liabilities (current) | €272.0K | €242.0K |
| Trade & other payables | €2.3M | €1.8M |
| Deferred tax liabilities | €14.0K | €19.0K |
| Derived metrics | ||
| Free cash flow | €1.8M | €1.5M |
| Operating margin | 14.9% | 8.6% |
| Net margin | 14.5% | 10.1% |
| Return on equity | 30.3% | 25.7% |
| Cash conversion ratio | 1.49× | 1.43× |
| Capex coverage | 2.04× | 3.68× |
| Other reported items | ||
| Adjustments For Decrease Increase In Contract Assets | -€123.0K | €222.0K |
| Adjustments For Decrease Increase In Inventories | €12.0K | -€29.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€381.0K | -€186.0K |
| Adjustments For Deferred Tax Expense | -€109.0K | -€397.0K |
| Adjustments For Depreciation Expense | €1.4M | €1.6M |
| Adjustments For Finance Income Cost | -€180.0K | -€189.0K |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€254.0K | -€223.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | €425.0K | -€403.0K |
| Adjustments For Provisions | €77.0K | €18.0K |
| Borrowings | €2.5M | €2.5M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €3.7M | €2.6M |
| Comprehensive Income Attributable To Noncontrolling Interests | €0 | €0 |
| Comprehensive Income Attributable To Owners of Parent | €2.7M | €1.6M |
| Current Contract Assets | €464.0K | €341.0K |
| Current Tax Liabilities | €197.0K | €25.0K |
| Deferred Tax Assets | €2.1M | €2.0M |
| Equity and Liabilities | €17.2M | €15.0M |
| Finance Income | €8.0K | €0 |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €129.0K | €61.0K |
| Income Taxes Paid Refund Classified As Operating Activities | -€22.0K | €0 |
| Increase Decrease In Cash and Cash Equivalents | €1.1M | €1.2M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€429.0K | — |
| Increase Decrease Through Exercise of Options | — | €36.0K |
| Increase Decrease Through Transactions With Owners | €5.6M | €4.0M |
| Interest Paid Classified As Operating Activities | €123.0K | €136.0K |
| Issue of Equity | — | €0 |
| Issued Capital | €8.3M | €8.3M |
| Noncurrent Provisions | €155.0K | €78.0K |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €3.9M | €4.6M |
| Other Comprehensive Income | €316.0K | €148.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €316.0K | €148.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Revaluation | €0 | €0 |
| Other Expense By Function | €2.4M | €2.3M |
| Other Reserves | €120.0K | €120.0K |
| Payments For Debt Issue Costs | €0 | €27.0K |
| Proceeds From Issue of Ordinary Shares | €0 | €36.0K |
| Proceeds From Noncurrent Borrowings | €0 | €892.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €0 | €8.0K |
| Repayments of Bonds Notes and Debentures | €400.0K | €0 |
| Retained Earnings | -€25.0M | -€27.9M |
| Revaluation Surplus | €1.8M | €1.9M |
| Share Premium | €20.7M | €20.7M |
Every line item above is a fact tagged in RoodMicrotec N.V.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.